Evidence map›Paper›PMID 36014415›Full record

ArticleMolecules (Basel, Switzerland)2022

In Silico and In Vitro Studies of

Relja Suručić, Jelena Radović Selgrad, Tatjana Kundaković-Vasović, Biljana Lazović, Maja Travar, Ljiljana Suručić, Ranko Škrbić

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Antimicrobial Activity ofCurrent issues in molecular biology · 2026
    Article
  3. Article
  4. Antihyperglycemic Activity ofMolecules (Basel, Switzerland) · 2025
    Article
  5. Effect ofNutrients · 2025
    Article
  6. Natural products as a source of Coronavirus entry inhibitors.Frontiers in cellular and infection microbiology · 2024
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Relja SuručićDepartment of Pharmacognosy, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina.
Jelena Radović SelgradDepartment of Pharmacognosy, Faculty of Pharmacy, University of Belgrade, VojvodeStepe 450, 11221 Belgrade, Serbia.
Tatjana Kundaković-VasovićDepartment of Pharmacognosy, Faculty of Pharmacy, University of Belgrade, VojvodeStepe 450, 11221 Belgrade, Serbia.ORCID 0000-0001-5777-8612
Biljana LazovićInternal Medicine Clinic, Division of Pulmonology, University Clinical Hospital Center Zemun, 11080 Belgrade, Serbia.
Maja TravarDepartment of Microbiology, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina.
Ljiljana SuručićDepartment of Organic Chemistry, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina.ORCID 0000-0003-4332-8690
Ranko ŠkrbićDepartment of Pharmacology, Toxicology and Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, 78000 Banja Luka, Bosnia and Herzegovina.ORCID 0000-0002-6643-1781
University of Banja Luka · BAUniversity of Belgrade · RSZemun Hospital · RS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the outbreak of the COVID-19 pandemic, it has been obvious that virus infection poses a serious threat to human health on a global scale. Certain plants, particularly those rich in polyphenols, have been found to be effective antiviral agents. The effectiveness of

Indexed as

AlchemillaCOVID-19 Drug TreatmentAngiotensin-Converting Enzyme 2HumansMolecular Docking SimulationMutationPandemicsPeptidyl-Dipeptidase APolyphenolsProtein BindingSARS-CoV-2Spike Glycoprotein, CoronavirusVirus InternalizationAngiotensin-Converting Enzyme 2Peptidyl-Dipeptidase APolyphenolsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Alchemilla viridiflora Rothm.COVID-19in silicoin vitroneuropilin-1polyphenolsSARS-CoV-2spike glycoprotein

Identifiers

PMID36014415
PMCPMC9415016
OpenAlexW4291512450

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.